Intrinsic leukemic stem cells (LSCs) overexpress several immune checkpoint molecules, including PD-L1, TIM-3, and CD276, which not only suppress T-cell responses but also exert tumor-intrinsic effects that promote survival, proliferation, and stemness [155]. This evidence concerns the gene CD274 and neoplasm.